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Abstract 
Platelet distribution width (PDW) is a simple and inexpensive parameter, which could 
predict activation of coagulation efficiently. And it has been confirmed to have a significant 
role in many diseases. We aimed to explore the association between PDW and 
hyperuricemia in a large Chinese cohort. This cross-sectional 
study recruited 61091 ostensible healthy participants 
(29259 male, 31832 female) after implementing exclusion criteria. Clinical data of the 
enrolled population included anthropometric measurements and serum parameters. Database 
was sorted by gender, and the association between PDW and hyperuricemia was analyzed after 
dividing PDW into quartiles. Crude and adjusted odds ratios (OR) of 
PDW for hyperuricemia with 95% confidence intervals were analyzed by binary logistic 
regression models. We found no significant difference in PDW values between the genders. 
Males showed significantly higher incidence of hyperuricemia than femals. From 
binary logistic regression models, significant hyperuricemia risks only were demonstrated 
in PDW quartiles 2 and 3 in males (p<0.05). This study displayed close association 
between PDW and hyperuricemia as a risk factor. It is meaningful to use PDW as 
a clinical risk predictor for hyperuricemia in males. 
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 1. Introduction 
Hyperuricemia is a state of abnormally high level of uric acid (UA) in the blood. A 
number of epidemiologic studies have indicated that hyperuricemia is closely associated with 
a wide range of diseases, such as type 2 diabetes mellitus(1), hypertension(2, 3), obesity(4), 
incident kidney disease(5), metabolic syndrome(6, 7), stroke(8), heart failure(9), thyroid 
disorders(10), peripheral artery disease(11) and et al. Platelet distribution width 
(PDW), which is considered as one of integral components in the general assessment 
of platelet (PLT) function, is a morphometric index as well as quantitative measure of size 
distribution and variability of PLT(12). In recent years, PDW has also been identified to be 
related with many diseases just like hyperuricemia, such as myocardial 
infarction(13), carotid artery stenosis(14, 15), type 2 diabetes mellitus(16), obesity(17), acute 
appendicitis(18), bone mineralization(19), contrast-induced nephropathy(20) and et al. Based 
on these phenomena, we may wonder whether PDW and hyperuricemia could 
be related. Therefore, in the present study, we sought to determine the association 
between PDW and hyperuricemia in a gender-specific manner in a representative sample of 
Tianjin municipality population. 
  
2. Methods 
2.1. Design 
We used data from a cross-sectional, community-based health-check investigation in 
Tianjin Medical University General Hospital. The rational and methodology have been 
reported previously(7, 21-24, 10, 25-30). In brief, a questionnaire was self reported by the 
ostensible healthy participants, who came to our institution for the annual medical 
checkup. And a blood sample was obtained subsequently for each person. In order to avoid 
the confounding factors, exclusion criteria were exercised for the following situations: 
participants with histories of hematological, hepatic, renal, gastro-intestinal, inflammatory, 
infectional, thyroidal, oncological or immunological diseases; subjects taking any medicine 
that might influence hematology, UA level, thyroid, inflammation, infection or immune; 
pregnancy. For the purpose of this particular study, a total of 61091 eligible subjects 
(29259 male, 31832 female) with adequate data for analysis were compiled and included 
during the period from September 2010 to September 2015. The institutional review board and 
ethic committee of Tianjin Medical University General Hospital approved this study. And all 
of participants provided their written consents.d pressure (SBP), diastolic blood 
pressure (DBP), ALT, TBIL, BUN, Cr, UA, TC, TG, HDL, WBC, RBC, PLT, 
PDW and MPV were significantly different between two genders. However,there was no 
significant difference in LDL values between the two genders. 
3.2. UA values based on different genders and PDW groups 
We used different quartiles for different data sets for Kruskal-Wallis test (Table 2, Figure 
1). In total data, statistics for PDW subgroups was 2=13.779 (P<0.01). Further Mann-
Whitney U test revealed that the differences in UA between each two groups of PDW ≤11.20, 
11.20< PDW ≤12.30, 12.30< PDW ≤13.70 and PDW >13.70; and the differences between 
PDW ≤11.20 and PDW >13.70(P<0.01), the differences between 11.20< PDW ≤12.30 and 
PDW >13.70(P<0.01), and the differences between 12.30< PDW ≤13.70 and 
PDW >13.70 were significant (P<0.05). 
In males, the statistics for PDW subgroups was 2=35.250 (P<0.01). Further Mann-
Whitney U test revealed that the differences in UA between each two groups of PDW ≤11.10, 
11.10< PDW ≤12.20, 12.20< PDW ≤13.60 and PDW >13.60; and the differences between 
PDW ≤11.10 and 11.20< PDW ≤12.30 (P<0.01), and the differences between PDW 
≤11.10 and 12.20< PDW ≤13.60 (P<0.01), and the differences between PDW ≤11.10 and 
PDW >13.60 were significant (P<0.01). 
Furthermore, in females, the statistics for PDW subgroups 
was 2=12.691 (P<0.01). Further Mann-Whitney U test revealed that the differences in UA 
between each two groups of PDW ≤11.30, 11.30< PDW ≤12.30, 12.30< PDW ≤13.80 
and PDW >13.80; and the differences between PDW ≤11.30 and 12.30< PDW 
≤13.80 (P<0.05), and the differences between 11.30< PDW 
≤12.30 and PDW >13.80 (P<0.01), and the differences between 12.30< PDW 
≤13.80 and PDW >13.80 were significant (P<0.01). 
3.3. Correlations between PDW and other key variables 
The results of the Pearson bivariate correlations between PDW and other variables based 
on different genders showed that PDW demonstrated 
significant negative relationships with some variables, including age, PLT and UA in males, as 
well as age, RBC, PLT and UA in females (Table 3). In addition, 
PDW showed significant positive relationships with some variables, including ALT, TBIL, 
TG, WBC and MPV in males, as well as BMI, ALT, TBIL and MPV in females. 
3.4. Incidence of hyperuricemia according to PDW quartiles 
PDW quartiles were calculated and respective incidence of hyperuricemia was compared 
between genders. Males showed significantly higher overall incidence 
of hyperuricemia than females. Detailed incidences inPDW quartiles showed an increasing 
trend among males, but this trend was not obvious in females (Table 4). 
3.5 Diagnostic value of PDW for hyperuricemia 
From receiver operating characteristic (ROC) 
analysis, PDW demonstrated limited diagnostic and predictive values for hyperuricemia in 
males, while, there is no statistical value of PDW in females. Areas under the curves were 
found to be 0.514 (p<0.01) in males and 0.508 (p>0.05) in females respectively. Cut-off value 
for males was calculated to be 12.25%, diagnostic accuracy to be 51.813%, sensitivity to be 
50.037%, specificity to be 52.218%, PPV to be 19.258% and NPV to be 82.106%. 
3.6. Risks of hyperuricemia in different genders 
Binary logistic regression models were implemented to calculate the risks 
of hyperuricemia in different variables including age, BMI, ALT, TBIL, BUN, Cr, TC, TG, 
HDL, LDL, WBC, RBC, PLT and PDW (Table 5).Most parameters displayed detrimental 
effects for an association with hyperuricemia in both genders, except for TBIL in both genders 
and PDW in females. 
Moreover, binary logistic regression models were implemented to calculate the risks of 
hyperuricemia in different genders with the lowest PDW quartile as reference (Table 6). 
Significant risks were demonstrated for hyperuricemia in high PDW quartiles 
in males. Adjusted risk factors included age, BMI, ALT, BUN, Cr, TC, TG, HDL, LDL, WBC, 
RBC and PLT as covariates. After adjustment, significant risks maintained for 
hyperuricemia only in the second and third PDW quartile in males, while the result had no 
significance in females. 
  
4. Discussion 
There is one piece of previous evidence focusing on the independent 
association between PDW and UA. Tayefi et al.(31){Tayefi, 2018 #2060} showed a 
significant positive association between PLT and UA in hypertension patients, and PLT and 
PDW could be independent determinants of a high serum UA in newly diagnosed 
hypertensive patients. But this study had limitations of restricted case number, not focusing on 
gender differences, and all cases being hypertensive. The present 
study is a research focusing on the independent association between 
PDW and hyperuricemia in a huge sample size of health examination participants. And our 
study indicated that a high level of PDW could be associated with an 
increased risk for hyperuricemia only in males. 
The underlying reason of the relationship between PDW and hyperuricemia deserves 
discussion. We postulate that the serum UA may affect the value of PDW by affecting PLTs in 
different ways. Firstly, serum UA has a low physical solubility in the blood. A 
high concentration of serum UA is easy to form urate crystals and to deposit in the blood 
vessel walls which could damage vascular endothelial cells and activate PLTs. Then the 
aggregation function of PLTs will increase, which will show up as the increased cell surface 
granule membrane protein expression and then being released into the blood(32). Secondly, a 
high UA concentration could impair endothelium-dependent vasodilatation 
significantly by activating the renin-angiotensin system. Activated renin-angiotensin 
system could not only increase renin activity and the adhesion and aggregation of PLTs,but 
also reduce nitric oxide production via inhibiting nitric oxide synthase synthesis, which could 
also enhance PLT activation(33). Thirdly, a high level of UA also promotes LDL 
cholesterol oxidating and lipid peroxidating. 
Oxidized LDL activates PLTs via combining with lipoprotein specific binding sites on PLTs’ 
surface(34). Fo, oxidative stress response caused by hyperuricemia can activate WBCs and 
promote adhesion of leukocytes and endothelial cells, and has a positive correlation with the 
level of inflammatory cytokines in vivo, suggesting that blood UA involved in vascular 
inflammation. Besides, UA causes vascular injury through inflammatory reactions, 
complements activation through classical and alternative pathways, mast 
cells stimulation, and PLTs and enhance thrombosis activation. has All the above changes 
have been reported to be the mechanisms of developing cardiovascular and cerebrovascular 
diseases(35, 36). Fifthly, it has been suggested that serum UA has a significant positive 
correlation with C-reactive protein (CRP), a soluble inflammatory marker(37). It has also 
been confirmed that a significant positive correlation 
between CRP and thrombopoietin exists(38), thus it can be deduced that 
CRP and thrombopoietin could play a crucial role in promoting the generation of PLT 
and affecting PLT activity. Besides, PLT is independently related to the level of CRP, which 
is regarded as the underlining reason linking PLT and inflammation(39). Finally, as we all 
know that PDW is a direct flow cytometric measurement of PLT cell volume. And it has been 
confirmed that PDW increases during PLT activation and it could predict activation of 
coagulation efficiently(40). From the above, we could hold the opinion that hyperuricemia is 
closely related with PDW increasement, which means that we could reflect the level of serum 
UA through different values of PDW. 
PDW showed significant effect for hyperuricemia in males, while no significance 
in females in the current study. About this phenomenon, we think it should be 
related with sex hormones. Evidence that gender differences play a role in PLT reactivity has 
been confirmed in previous studies(41). And it has also been observed that women have a 
higher magnitude of PLT reactivity than men(42). The process by which megakaryocytes 
proceed to proplatelet formation and production of PLTs is reportedly under the influence of 
autocrine estrogen(43). Additionally, estrogen-receptor antagonists inhibit PLT production in 
vivo, supporting a role of estrogen in PLT production(44). On the other hand, UA is generally 
higher in male than female after sexual maturity, while this difference decreases after 
menopause. This means that female hormone of estrogenhas a significant protective effect 
against hyperuricemia. The current study indicated although the levels of PDW were not 
significantly different between genders (Table 1), the male-dominance phenomenon of 
hyperuricemia still existed in terms of PDW-based gender difference (Table 6). It could be 
deduced that sex hormones could be the inherent driving force, making such a difference. 
There are several limitations in this study. First, causality relationship cannot be 
determined in such a cross-sectional designed study. Prospective or interventional 
investigations should be conducted in the future. Second, lifestyle factors, such as dietary 
habits, exercise frequency might influence serum UA and PDW values but was not recorded in 
details as confounding factors. Third, we checked blood parameters only once, andwe did 
not measure sex hormones and inflammatory factors, these are due to budget 
shortage. Fourth, although we applied strict exclusion criteria to rule our PDW 
influencing diseases, a number of the participants withvarious diseases might not be aware 
of their medical conditions, which could be a confounding factor in our research. 
In conclusion, the current study proves that PDW and hyperuricemia are closely 
related. A high level of PDW is associated with a high risk of hyperuricemia in males. It 
seems reasonable to suggest that the assessment of PDW, a simple and inexpensive 
parameter, could be used as a clinical risk predictor for hyperuricemia in males. 
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